Pro-A-type natriuretic peptide, proadrenomedullin, and n-terminal pro-b-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure

Journal of Cardiac Failure

Volumn 19, Issue 1, 2013, Pages 31-39

  Alehagen, Urban ^a,b   Dahlström, Ulf ^a,b   Rehfeld, Jens F ^c   Goetze, Jens P ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Elderly; heart failure; mulitmarker testing; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; PROADRENOMEDULLIN;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADRENOMEDULLIN; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NATRIURETIC PEPTIDE, BRAIN; NORMAL DISTRIBUTION; PEPTIDE FRAGMENTS; PRIMARY HEALTH CARE; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS;

EID: 84871872538     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.11.002     Document Type: Article

References (22)

1. A. Clerico, and M. Emdin Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review Clin Chem 50 2004 33 50
2. S. Masson, R. Latini, I.S. Anand, T. Vago, L. Angelici, and S. Barlera Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data Clin Chem 52 2006 1528 1538
3. F. Hartmann, M. Packer, A.J. Coats, M.B. Fowler, H. Krum, and P. Mohacsi Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial Circulation 110 2004 1780 1786
4. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, and M. Santalo-Bel NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
5. U. Alehagen, G. Lindstedt, L.A. Levin, and U. Dahlstrom Risk of cardiovascular death in elderly patients with possible heart failure B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population Int J Cardiol 100 2005 125 133
6. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 2004 234 236
7. S. von Haehling, E.A. Jankowska, N.G. Morgenthaler, C. Vassanelli, L. Zanolla, and P. Rozentryt Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure J Am Coll Cardiol 50 Nov 13 2007 1973 1980
8. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
9. U. Alehagen, H. Eriksson, E. Nylander, and U. Dahlström Heart failure in the elderly. Characteristics of a Swedish primary health care population Heart Drug 2 2002 211 220
10. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
11. A.M. Choy, D. Darbar, C.C. Lang, T.H. Pringle, G.P. McNeill, and N.S. Kennedy Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods Br Heart J 72 1994 16 22
12. K. Jensen-Urstad, F. Bouvier, J. Hojer, H. Ruiz, J. Hulting, and B. Samad Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy Am J Cardiol 81 Mar 1 1998 538 544
13. N. van Royen, C.C. Jaffe, H.M. Krumholz, K.M. Johnson, P.J. Lynch, and D. Natale Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 1996 843 850
14. P. Caruhel, C. Mazier, J. Kunde, N.G. Morgenthaler, and B. Darbouret Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system Brahms Kryptor Clin Biochem 42 2009 725 728
15. S. Masson, R. Latini, I.S. Anand, S. Barlera, L. Angelici, and T. Vago Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
16. U. Alehagen, and U. Dahlstrom Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure Int J Cardiol 133 2009 233 240
17. J. Rosenberg, M. Schou, F. Gustafsson, J. Badskjaer, and P. Hildebrandt Prognostic threshold levels of NT-proBNP testing in primary care Eur Heart J 30 2009 66 73
18. M. Lainscak, M.S. Anker, S. von Haehling, and S.D. Anker Biomarkers for chronic heart failure: diagnostic, prognostic, and therapeutic challenges Herz 34 2009 589 593
19. G.C. Fonarow, W.F. Peacock, T.B. Horwich, C.O. Phillips, M.M. Givertz, and M. Lopatin Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE Am J Cardiol 101 2008 231 237
20. M.N. Zairis, G.Z. Tsiaousis, A.T. Georgilas, S.S. Makrygiannis, E.N. Adamopoulou, and S.M. Handanis Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure Int J Cardiol 141 2010 284 290
21. W.H. Yin, J.W. Chen, A.N. Feng, S.J. Lin, and S. Young Multimarker approach to risk stratification among patients with advanced chronic heart failure Clin Cardiol 30 2007 397 402
22. A. Maisel, C. Mueller, R. Nowak, W.F. Peacock, J.W. Landsberg, and P. Ponikowski Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076